http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2204833-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_247236b55d669537e215f1171850b947 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24460c15f51608768a0d0c5539adb0e0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-0295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-49 |
| filingDate | 2000-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5ddc0e46f7b09efaf5c82d65d339fbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dea6fca85927fac76f60e8b14b549084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64d974c5254c5138e78b0d0676acc97e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22322e65a342f03a51ea69e3b621b44c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af80f929a7a70366b46961a285abb7b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646a8f5a2b3bacbf2795dbec17a67a21 |
| publicationDate | 2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2204833-C2 |
| titleOfInvention | Method for predicting development of polyorganic failure (pof) based upon informative values of homeostasis studied at the first trimester of pregnancy |
| abstract | FIELD: medicine, obstetrics. SUBSTANCE: in the first trimester of pregnancy on should study the quantity of free endotheliocytes, level of D-dimers, fibrinogen, the number of thrombocytes and that of type III lymphocytes, the level of interleukin-6, index of leukocytic activity, total peripheral vascular resistance (TPVR), based upon these values one should calculate F value by the formula, at F above 0 it is possible to conclude that pregnant woman potentially belongs to risk group for POF development, at F under 0 - that pregnant woman belongs to the group where POF won't be developed during pregnancy course. The method enables to detect patients belonging to risk group for POF development earlier and prescribe corresponding therapy. EFFECT: higher efficiency of prediction. 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2482797-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2585143-C1 |
| priorityDate | 2000-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.